The Hong Kong Private Equity group led a cross-office Goodwin team on advising Templewater and its portfolio company, TW Pengu Holdings Limited (“TWPHL”), on their acquisition of Icon Group’s Hong Kong assets. Icon Group is Australia's largest integrated provider of cancer care with a growing reach in New Zealand, Asia and the United Kingdom. The Goodwin Hong Kong team has recently advised Templewater on multiple healthcare acquisitions in Singapore, the Philippines, and Malaysia, including the acquisition of Singapore Breast Surgery Centre, Central Luzon Integrated Oncology Centre, Can-Care, OncoCare and Novena Heart Centre.
Templewater is an alternative asset management firm headquartered in Hong Kong. Templewater provides investment solutions to institutions, entrepreneurs, and family offices across various asset classes including private equity, impact investing, and real estate. Its private equity strategy focuses on mid-market control buyout opportunities in the Asia Pacific. TWPHL’s objective is to develop a premier oncology group in Asia to attract leading doctors and practices across multiple jurisdictions to enable patients to receive the best treatment and services across all stages of the treatment journey.
The Goodwin team was led by Edwin Chan and included Ingram Cheung, Samson Peng, Gabriel Lee, Billy Chong and Monique Chan (PE M&A), Steve Howard and Dora Cheung (Debt Finance), and Ai Tajima (Risk Management & Insurance), David Chen, Neel Sitaramya (Life Sciences/Privacy/IP), Dulcie Daly, Nathan Langford (Tax), Ce “Charles” Li (Global Trade), William Stern (Financial Services), with invaluable assistance from Daniel Dusek (PE M&A), Jacob Osborn (Global Trade) and Saba Rais (Executive Compensation).
For more information on the deal, please read the press release.